These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23205080)

  • 41. Advances in the development of retinoids as chemopreventive agents.
    Lippman SM; Lotan R
    J Nutr; 2000 Feb; 130(2S Suppl):479S-482S. PubMed ID: 10721933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer.
    Li D; Yamada T; Wang F; Vulin AI; Samuels HH
    J Biol Chem; 2004 Feb; 279(9):7427-37. PubMed ID: 14668324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular characterization of human thyroid hormone receptor β isoform 4.
    Moriyama K; Yamamoto H; Futawaka K; Atake A; Kasahara M; Tagami T
    Endocr Res; 2016; 41(1):34-42. PubMed ID: 26513165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimers.
    Winrow CJ; Miyata KS; Marcus SL; Burns K; Michalak M; Capone JP; Rachubinski RA
    Mol Cell Endocrinol; 1995 Jun; 111(2):175-9. PubMed ID: 7556879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
    Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
    Araki O; Ying H; Furuya F; Zhu X; Cheng SY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
    Han JS; Crowe DL
    BMC Cancer; 2010 Nov; 10():629. PubMed ID: 21080969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
    Matkovits T; Christakos S
    Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.
    Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA
    Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
    Lemon BD; Freedman LP
    Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation effects of zinc on the formation of vitamin D receptor and retinoid X receptor alpha-DNA transcription complexes: analysis by microelectrospray mass spectrometry.
    Craig TA; Benson LM; Naylor S; Kumar R
    Rapid Commun Mass Spectrom; 2001; 15(12):1011-6. PubMed ID: 11400211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel sequence determinants in peroxisome proliferator signaling.
    Palmer CN; Hsu MH; Griffin HJ; Johnson EF
    J Biol Chem; 1995 Jul; 270(27):16114-21. PubMed ID: 7608174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system.
    Cullingford TE; Bhakoo K; Peuchen S; Dolphin CT; Patel R; Clark JB
    J Neurochem; 1998 Apr; 70(4):1366-75. PubMed ID: 9523552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor.
    Nuñez SB; Medin JA; Braissant O; Kemp L; Wahli W; Ozato K; Segars JH
    Mol Cell Endocrinol; 1997 Mar; 127(1):27-40. PubMed ID: 9099898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors.
    Miyamoto T; Kakizawa T; Ichikawa K; Nishio S; Takeda T; Suzuki S; Kaneko A; Kumagai M; Mori J; Yamashita K; Sakuma T; Hashizume K
    Mol Cell Endocrinol; 2001 Jul; 181(1-2):229-38. PubMed ID: 11476956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.